SOLUFERON

Welcome to the Brand page for “SOLUFERON”, which is offered here for Pharmaceutical and veterinary products, interferons for treating diseases of the immune system, multiple sclerosis, dldp (chronic inflammatory demyelinating polyradiculoneuropathy), viral infections, hepatitis b, hepatitis c, ulcerative colitis, sars, hlv, htlv, condylomaacuminata, papilloma virus, cancer, malignant melanoma, colorectal cancer, breast cancer, liver cancer, cervical cancer, head and neck squamous tumors; cultures of microorganisms and preparations derived thereof for medical or veterinary purposes, including clinical or medical laboratory use;chemical preparations for scientific purposes; cultures of microorganisms and preparations derived thereof for laboratories other than for medical or veterinary purposes;scientific and technological services and research relating thereto, especially scientific research for medical purposes; services of chemists, biologists, biochemists or biotechnologists; drawing up expert opinions relating to subjects from natural science or medicine; scientific and technical project evaluations; technical project management for research and development projects in the field of natural sciences or medicine, conducting clinical and scientific studies; industrial analysis and research services; development of new technology and products for others on the basis of research results in the field of natural sciences and medicine, including development of pharmaceutical preparations and medicines; exploitation of rights to results of research and pharmaceutical products; licensing of intellectual property;.

Its status is currently believed to be active. Its class is unavailable. “SOLUFERON” is believed to be currently owned by “Vakzine Projekt Management GmbH”.